72 related articles for article (PubMed ID: 6085380)
1. Calcium antagonists and excitation of the vascular muscle membrane.
Hermsmeyer K; Kuthe C
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S933-6. PubMed ID: 6085380
[TBL] [Abstract][Full Text] [Related]
2. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
[TBL] [Abstract][Full Text] [Related]
3. Nitrendipine inhibition of calcium current in rat vascular muscle cells.
Hermsmeyer K; Sturek M; Rusch NJ
J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S100-3. PubMed ID: 2469865
[TBL] [Abstract][Full Text] [Related]
4. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
Altura BM; Altura BT
Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
[TBL] [Abstract][Full Text] [Related]
5. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
Nielsen-Kudsk JE
Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcium antagonists on aortae isolated from normotensive and hypertensive rats: relaxation and calcium influx blockade.
Cattaneo EA; Rinaldi GJ; Cingolani HE
Can J Cardiol; 1990 Jun; 6(5):212-8. PubMed ID: 2383793
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
Zakhari S
Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological basis for use of calcium antagonists in hypertension.
Scriabine A; Kazda S
Magnesium; 1989; 8(5-6):253-65. PubMed ID: 2693846
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of Ca2+-induced constriction of isolated rabbit ear artery by nitrendipine in high K+- and/or norepinephrine-containing medium.
Scriabine A; Johnson CE; Steinsland OS; Anderson CL
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S944-8. PubMed ID: 6085382
[TBL] [Abstract][Full Text] [Related]
10. Some recent pharmacological findings with nitrendipine.
Scriabine A; Anderson CL; Janis RA; Kojima K; Rasmussen H; Lee S; Michal U
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S937-43. PubMed ID: 6085381
[TBL] [Abstract][Full Text] [Related]
11. Involvement of calcium channels in fibroblast growth factor-induced activation of arterial cells in spontaneously hypertensive rats.
Zhu DL; Hérembert T; Caruelle D; Caruelle JP; Marche P
J Cardiovasc Pharmacol; 1994 Mar; 23(3):395-400. PubMed ID: 7515982
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.
Liu H; Sperelakis N
Can J Physiol Pharmacol; 1997 Sep; 75(9):1063-8. PubMed ID: 9365814
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic captopril, but not prazosin or nifedipine, normalize alterations in adrenergic intracellular Ca2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats.
Miquel R; Gisbert R; Serna E; Perez-Vizcaino F; Anselmi E; Noguera MA; Ivorra MD; D'Ocon MP
J Pharmacol Exp Ther; 2005 Apr; 313(1):359-67. PubMed ID: 15615866
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel function in hypertension.
Hermsmeyer K
J Hum Hypertens; 1993 Apr; 7(2):173-6. PubMed ID: 8389872
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane calcium pump-mediated calcium efflux and bulk cytosolic free calcium in cultured aortic smooth muscle cells from spontaneously hypertensive and Wistar-Kyoto normotensives rats.
Monteith GR; Kable EP; Chen S; Roufogalis BD
J Hypertens; 1996 Apr; 14(4):435-42. PubMed ID: 8761891
[TBL] [Abstract][Full Text] [Related]
16. Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Fleckenstein-Grün G; Thimm F; Czirfuzs A; Matyas S; Frey M
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S75-84. PubMed ID: 7898099
[TBL] [Abstract][Full Text] [Related]
17. Dihydropyridines inhibit acetylcholine-induced hyperpolarization in cochlear artery via blockade of intermediate-conductance calcium-activated potassium channels.
Jiang ZG; Shi XR; Guan BC; Zhao H; Yang YQ
J Pharmacol Exp Ther; 2007 Feb; 320(2):544-51. PubMed ID: 17082310
[TBL] [Abstract][Full Text] [Related]
18. Effect of docosahexaenoic acid on intracellular calcium dynamics in vascular smooth muscle cells from normotensive and genetically hypertensive rats.
Hirafuji M; Ebihara T; Kawahara F; Nezu A; Taminura A; Saito H; Minami M
Res Commun Mol Pathol Pharmacol; 1998 Oct; 102(1):29-42. PubMed ID: 9920344
[TBL] [Abstract][Full Text] [Related]
19. Characterization of enhanced 45Ca2+ efflux in cultured vascular smooth muscle cells from spontaneously hypertensive rats.
Chen S; Monteith GR; Roufogalis BD
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1015-22. PubMed ID: 8845070
[TBL] [Abstract][Full Text] [Related]
20. Clinical and pharmacological properties of calcium antagonists in essential hypertension in humans and spontaneously hypertensive rats.
Aoki K; Kawaguchi Y; Sato K; Kondo S; Yamamoto M
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S298-302. PubMed ID: 6184557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
